The AJMC® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.
December 10th 2025
Many US patients with diabetes cannot afford their medical care. The authors review the impact of interventions that reduced and/or eliminated diabetes-related costs.
The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation
1 Credit / Cardiology, Neurology
View More
Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care
1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health
View More
Self-Management Interventions Could Improve Outcomes for Low-Income Diabetics
February 10th 2017A study assessed the effectiveness of a support intervention delivered by community health workers in the homes of low-income diabetics and found that it may have improved outcomes for those with poor glycemic control.
Read More
This Week in Managed Care: February 10, 2017
February 10th 2017This week, the top managed care stories included final enrollment numbers for the Affordable Care Act for 2017, a report that revealed low rates of lung cancer screening, and a study found that a population-based weight management strategies can prevent diabetes.
Watch
Patient Communities: Mandi Bishop Interviews Christopher Snider
February 6th 2017In the latest Managed Care Cast, Mandi Bishop, MA, CEO of Aloha Health, interviews Christopher A. Snider, a patient community advocate for Symplur, creator of patient community site My Disease Secret, host of the Just Talking podcast, and social media strategist for Smart Patients.
Listen
Population-Level Weight Maintenance Programs Could Help Prevent Diabetes, Study Finds
February 6th 2017A recent study indicated that strategies to promote weight loss or maintenance across an entire population could be more effective in preventing type 2 diabetes than programs specifically targeting obese people at high risk of developing the disease.
Read More
Merck, Pfizer Publish Results for Ertugliflozin as Monotherapy in Type 2 Diabetes
February 2nd 2017Significant reductions in A1C were found at both doses, and bigger declines were seen among patients with the worst glycemic control. The cardiovascular outcomes trial for the SGLT2 inhibitor took a different turn after a rival drug showed a CV benefit.
Read More
PhRMA CEO Touts "Positive" Meeting With Trump
January 31st 2017According to pool reports, Trump proposed a series of carrots and sticks to woo drug manufacturing back to the United States and force other countries to pay more for therapies developed here. Trump called the US subsidization of drug development "global freeloading."
Read More
Dr Fatima Cody Stanford: Changing Obese Patients' Self-Perception Is Key
January 30th 2017Patients need help shaking off the negative stigma associated with obesity and improving their self-worth before they can start to work with clinicians on treating the disease process, said Fatima Cody Stanford, MD, MPH, MPA, FAAP, FTOS, of Harvard Medical School and Massachusetts General Hospital.
Watch